Related Experiment Video
Updated: May 5, 2026
10:29
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
2.0K
[Potential role of rilpivirine in simplification regimens]
José L Casado1, Santiago Moreno
1Departamento de Enfermedades Infecciosas, Hospital Ramón y Cajal, Madrid, España.
Enfermedades Infecciosas Y Microbiologia Clinica
|November 21, 2013
Summary
Antiretroviral simplification using rilpivirine, a nonnucleoside reverse transcriptase inhibitor (NNRTI), improves HIV treatment adherence and quality of life. This strategy demonstrates high efficacy and tolerability in various patient groups, supporting its clinical use.
Area of Science:
- Infectious Diseases
- Pharmacology
- Virology
Background:
- Antiretroviral therapy simplification enhances patient adherence and quality of life in HIV management.
- Newer antiretroviral drugs in once-daily or fixed-dose formulations offer improved tolerability and efficacy for long-term HIV treatment.
- Rilpivirine, a nonnucleoside reverse transcriptase inhibitor (NNRTI), presents a promising option for simplified HIV regimens.
Purpose of the Study:
- To evaluate the efficacy and tolerability of rilpivirine in HIV treatment simplification strategies.
- To assess the impact of switching from efavirenz to rilpivirine on viral load and adverse effects.
- To determine if maintaining virological efficacy and improving safety profiles are achievable when switching from protease inhibitors to rilpivirine.
Main Methods:
- Clinical trials assessed rilpivirine's antiviral efficacy and tolerability in treatment-naïve HIV patients.
- Studies evaluated switching from efavirenz to rilpivirine without dose adjustment.
- A large randomized study compared rilpivirine to protease inhibitors in patients on established therapy.
Main Results:
- Rilpivirine demonstrated high antiviral efficacy and a lower incidence of adverse effects in treatment-naïve patients.
- Switching from efavirenz to rilpivirine maintained efficacy without requiring dose adjustments.
- Patients switching from protease inhibitors to rilpivirine maintained virological efficacy with improved lipid profiles and cardiovascular risk scores.
Conclusions:
- Rilpivirine is an effective and well-tolerated option for simplifying antiretroviral regimens in HIV patients.
- Simplification with rilpivirine can lead to improved tolerability, lipid parameters, and cardiovascular risk.
- The ease of administration and favorable safety profile of rilpivirine support its rapid adoption in clinical practice for HIV management.
Related Concept Videos
01:10Retrovirus Life Cycles
43.1K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
43.1K
01:30Inhibitors of Viral Protein Synthesis
73
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
73
02:33Retroviruses
12.2K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.2K
01:29Subviral Agents
940
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
940